A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

NCT04673864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension and Dyslipidemia

Interventions

DRUG: CKD-386
DRUG: D012, D326, D337

Sponsor

Chong Kun Dang Pharmaceutical